Functional polymorphisms in microRNAs and susceptibility to liver cancer: A meta-analysis and meta-regression

Genetics and Molecular Research

Volumn 13, Issue 3, 2014, Pages 5426-5440

  Wang, B S ^a   Liu, Z ^a   Xu, W X ^a   Sun, S L ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Liver cancer; Meta analysis; MicroRNA; Single nucleotide polymorphism

Indexed keywords

MICRORNA; MICRORNA 106B 25; MICRORNA 122; MICRORNA 146A; MICRORNA 196A 2; MICRORNA 218; MICRORNA 34B; MICRORNA 34C; MICRORNA 499; MICRORNA 920; MICRORNA LET 7C; UNCLASSIFIED DRUG;

ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; DOMINANT INHERITANCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INDEL MUTATION; LIVER CANCER; RECESSIVE INHERITANCE; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; ALLELE; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MODEL; CAUCASIAN; ETHNOLOGY; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; LIVER TUMOR; META ANALYSIS; PATHOLOGY; RISK;

ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LIVER NEOPLASMS; MICRORNAS; MODELS, GENETIC; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84905014924     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2014.July.24.22     Document Type: Article

References (39)

1. Adams BD, Furneaux H and White BA (2007). The micro-ribonucleic acid (miRNA) miR-206 targets the human estrogen receptor-alpha (ERalpha) and represses ERalpha messenger RNA and protein expression in breast cancer cell lines. Mol. Endocrinol.21: 1132-1147.
2. Akkiz H, Bayram S, Bekar A, Akgollu E, et al. (2011a). A functional polymorphism in pre-microRNA-196a-2 contributes to the susceptibility of hepatocellular carcinoma in a Turkish population: a case-control study. J. Viral Hepat.18: e399-e407.
3. Akkiz H, Bayram S, Bekar A, Akgollu E, et al. (2011b). Genetic variation in the microRNA-499 gene and hepatocellular carcinoma risk in a Turkish population: lack of any association in a case-control study. Asian Pac. J. Cancer Prev. 12: 3107-3112.
4. Akkiz H, Bayram S, Bekar A, Akgollu E, et al. (2011c). No association of pre-microRNA-146a rs2910164 polymorphism and risk of hepatocellular carcinoma development in Turkish population: a case-control study. Gene486: 104-109.
5. Chen S, He Y, Ding J, Jiang Y, et al. (2010). An insertion/deletion polymorphism in the 3' untranslated region of betatransducin repeat-containing protein (betaTrCP) is associated with susceptibility for hepatocellular carcinoma in Chinese. Biochem. Biophys. Res. Commun.391: 552-556.
6. Croce CM (2009). Causes and consequences of microRNA dysregulation in cancer. Nat. Rev. Genet.10: 704-714.
7. Dennis J, Hawken S, Krewski D, Birkett N, et al. (2011). Bias in the case-only design applied to studies of geneenvironment and gene-gene interaction: a systematic review and meta-analysis. Int. J. Epidemiol.40: 1329-1341.
8. El-Serag HB and Rudolph KL (2007). Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology132: 2557-2576.
9. Ferracin M, Veronese A and Negrini M (2010). Micromarkers: miRNAs in cancer diagnosis and prognosis. Expert Rev. Mol. Diagn.10: 297-308.
10. Gallo V, Egger M, McCormack V, Farmer PB, et al. (2012). Strengthening the Reporting of observational studies in Epidemiology: Molecular Epidemiology STROBE-ME. An extension of the STROBE statement. J. Epidemiol. Community Health66: 844-854.
11. Gao Y, He Y, Ding J, Wu K, et al. (2009). An insertion/deletion polymorphism at miRNA-122-binding site in the interleukin-1alpha 3' untranslated region confers risk for hepatocellular carcinoma. Carcinogenesis30: 2064-2069.
12. Guo J, Jin M, Zhang M and Chen K (2012). A genetic variant in miR-196a2 increased digestive system cancer risks: a meta-analysis of 15 case-control studies. PLoS One7: e30585.
13. He L and Hannon GJ (2004). MicroRNAs: small RNAs with a big role in gene regulation. Nat. Rev. Genet.5: 522-531.
14. Higgins JP and Thompson SG (2002). Quantifying heterogeneity in a meta-analysis. Stat. Med.21: 1539-1558.
15. Ioannidis JP and Lau J (1999). Pooling research results: benefits and limitations of meta-analysis. Jt. Comm J. Qual. Improv.25: 462-469.
16. Ioannidis JP, Patsopoulos NA and Rothstein HR (2008). Reasons or excuses for avoiding meta-analysis in forest plots. BMJ336: 1413-1415.
17. Jemal A, Bray F, Center MM, Ferlay J, et al. (2011). Global cancer statistics. CA Cancer J. Clin.61: 69-90.
18. Kim WH, Min KT, Jeon YJ, Kwon CI, et al. (2012). Association study of microRNA polymorphisms with hepatocellular carcinoma in Korean population. Gene504: 92-97.
19. Kota J, Chivukula RR, O'Donnell KA, Wentzel EA, et al. (2009). Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell137: 1005-1017.
20. Liu Y, Pan S, Liu L, Zhai X, et al. (2012a). A genetic variant in long non-coding RNA HULC contributes to risk of HBVrelated hepatocellular carcinoma in a Chinese population. PLoS One7: e35145.
21. Liu Y, Zhang Y, Wen J, Liu L, et al. (2012b). A genetic variant in the promoter region of miR-106b-25 cluster and risk of HBV infection and hepatocellular carcinoma. PLoS One7: e32230.
22. Negrini M, Nicoloso MS and Calin GA (2009). MicroRNAs and cancer-new paradigms in molecular oncology. Curr. Opin. Cell Biol.21: 470-479.
23. Peters JL, Sutton AJ, Jones DR, Abrams KR, et al. (2006). Comparison of two methods to detect publication bias in metaanalysis. JAMA295: 676-680.
24. Qi P, Dou TH, Geng L, Zhou FG, et al. (2010). Association of a variant in MIR 196A2 with susceptibility to hepatocellular carcinoma in male Chinese patients with chronic hepatitis B virus infection. Hum. Immunol.71: 621-626.
25. Qiu LX, Wang Y, Xia ZG, Xi B, et al. (2011). miR-196a2 C allele is a low-penetrant risk factor for cancer development. Cytokine56: 589-592.
26. Ryan BM, Robles AI and Harris CC (2010). Genetic variation in microRNA networks: the implications for cancer research. Nat. Rev. Cancer10: 389-402.
27. Thun MJ, DeLancey JO, Center MM, Jemal A, et al. (2010). The global burden of cancer: priorities for prevention. Carcinogenesis31: 100-110.
28. Wang J, Wang Q, Liu H, Shao N, et al. (2012a). The association of miR-146a rs2910164 and miR-196a2 rs11614913 polymorphisms with cancer risk: a meta-analysis of 32 studies. Mutagenesis27: 779-788.
29. Wang X, Zhang X, Qiu B, Tang Y, et al. (2012b). MDM2 SNP309T>G polymorphism increases susceptibility to hepatitis B virus-related hepatocellular carcinoma in a northeast Han Chinese population. Liver Int.32: 1172-1178.
30. Wang Z, Cao Y, Jiang C, Yang G, et al. (2012c). Lack of association of two common polymorphisms rs2910164 and rs11614913 with susceptibility to hepatocellular carcinoma: a meta-analysis. PLoS One7: e40039.
31. Xiang Y, Fan S, Cao J, Huang S, et al. (2012). Association of the microRNA-499 variants with susceptibility to hepatocellular carcinoma in a Chinese population. Mol. Biol. Rep.39: 7019-7023.
32. Xu T, Zhu Y, Wei QK, Yuan Y, et al. (2008). A functional polymorphism in the miR-146a gene is associated with the risk for hepatocellular carcinoma. Carcinogenesis29: 2126-2131.
33. Xu W, Xu J, Liu S, Chen B, et al. (2011a). Effects of common polymorphisms rs11614913 in miR-196a2 and rs2910164 in miR-146a on cancer susceptibility: a meta-analysis. PLoS One6: e20471.
34. Xu Y, Liu L, Liu J, Zhang Y, et al. (2011b). A potentially functional polymorphism in the promoter region of miR-34b/c is associated with an increased risk for primary hepatocellular carcinoma. Int. J. Cancer128: 412-417.
35. Yu Q, Zhou CX, Chen NS, Zheng SD, et al. (2012). A polymorphism within ErbB4 is associated with risk for hepatocellular carcinoma in Chinese population. World J. Gastroenterol.18: 383-387.
36. Zhang LS, Liang WB, Gao LB, Li HY, et al. (2012). Association between pri-miR-218 polymorphism and risk of hepatocellular carcinoma in a Han Chinese population. DNA Cell Biol.31: 761-765.
37. Zhang XW, Pan SD, Feng YL, Liu JB, et al. (2011). Relationship between genetic polymorphism in microRNAs precursor and genetic predisposition of hepatocellular carcinoma. Zhonghua Yu Fang Yi. Xue. Za Zhi.45: 239-243.
38. Zhou J, Lv R, Song X, Li D, et al. (2012). Association between two genetic variants in miRNA and primary liver cancer risk in the Chinese population. DNA Cell Biol.31: 524-530.
39. Zintzaras E and Ioannidis JP (2005). Heterogeneity testing in meta-analysis of genome searches. Genet. Epidemiol.28: 123-137.